This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Effcon Laboratories, Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Nabil Rizk: Innovator in Pharmaceutical Formulations
Introduction
Nabil Rizk is a notable inventor based in Montville, NJ (US), recognized for his contributions to pharmaceutical formulations. With a total of four patents to his name, Rizk has made significant strides in the field of controlled release medications.
Latest Patents
Among his latest innovations is the extended release methazolamide formulation. This invention provides a once-a-day controlled release oral dosage form of methazolamide. The formulation comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. It is designed for once-daily administration, releasing methazolamide over a period of about twenty-four hours.
Career Highlights
Nabil Rizk has been instrumental in advancing pharmaceutical technologies through his work at Effcon Laboratories, Inc. His expertise in drug formulation has led to the development of innovative solutions that enhance patient compliance and therapeutic outcomes.
Conclusion
Nabil Rizk's contributions to the field of pharmaceutical formulations, particularly through his patented innovations, highlight his role as a key inventor in the industry. His work continues to impact the way medications are delivered to patients, improving their overall health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile